ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug BL-M05D1 tested in patients with advanced cancers
Disease control Recruiting nowThis early-stage study tests a new drug called BL-M05D1 in about 160 adults with advanced or metastatic solid tumors, including stomach, pancreatic, esophageal, and bile duct cancers. The main goals are to find safe doses and understand side effects. Participants must have tried …
Matched conditions: ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
New pill targets common cancer driver in advanced tumors
Disease control Recruiting nowThis early-phase study tests a new experimental drug called BGB-53038 in people with advanced or metastatic solid tumors that have a specific genetic change (KRAS mutation or amplification). The drug is a pan-KRAS inhibitor, meaning it aims to block many forms of the faulty KRAS …
Matched conditions: ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New nano drug aims to combat wasting in pancreatic cancer patients
Symptom relief Recruiting nowThis study tests a new nano-formulation of megestrol acetate in 56 patients with advanced pancreatic cancer who suffer from anorexia-cachexia syndrome, a condition causing severe appetite loss and weight loss. The goal is to see if the drug can help patients gain weight, improve …
Matched conditions: ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: NA • Sponsor: Shandong Cancer Hospital and Institute • Aim: Symptom relief
Last updated May 26, 2026 11:34 UTC